14 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... events in T2DM + ASCVD ... or ASCVD risk; ... or ASCVD risk. ... visualabstract #table
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
and Titration Algorithm ... - Established ASCVD ... or CKD - Without ... established ASCVD ... or CKD #Diabetes
Non-ACS Myocardial Injury - Elevated Troponin Differential Diagnosis and Workup Algorithm

 • Chronic Myocardial Injury: End
Myocardial Injury - Elevated ... Diagnosis and Workup Algorithm ... Occlusion • Stable ... Myocardial #Injury #Elevated ... Differential #Diagnosis #Algorithm
Causes of Metabolic Acidosis with Elevated Anion Gap - Differential Diagnosis Algorithm
Elevated Anion Gap > 12
Acidosis with Elevated ... Differential Diagnosis Algorithm ... Elevated Anion ... secretion • AKI/CKD ... Differential #Diagnosis #Algorithm
Hypocalcemia - Differential Diagnosis Algorithm
 • Low Serum Mg: GI losses, Renal losses, Alcoholism, Malnutrition, Drug-Induced
Differential Diagnosis Algorithm ... Intact PTH Level Elevated ... Hyperparathyroidism: CKD ... Differential #Diagnosis #Algorithm
Causes of Peripheral Weakness - With and Without Sensory Changes - Differential Diagnosis Algorithm
With Sensory Changes:
Differential Diagnosis Algorithm ... muscle involvement, elevated ... CK #Peripheral ... Differential #Diagnosis #Algorithm
Abnormal Liver Function Tests - Differential Diagnosis Algorithm for Transaminitis
Hepatocellular Pattern (ALT or AST > ALP):
Differential Diagnosis Algorithm ... Ducts - CBD ... kwburak #LFTs #Elevated ... Transaminitis #Algorithm
Causes of Peripheral Weakness without Sensory Changes - Differential Diagnosis Algorithm
No Objective Weakness
 • Cardio-pulmonary disease
Differential Diagnosis Algorithm ... muscle involvement, elevated ... CK • Polymyositis ... Differential #Diagnosis #Algorithm
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
factors: Age>60, CKD ... resp distress, elevated ... diagnosis #comparison #table
Rapid, increasing signs of extrapyramidal symptoms (EPS) is an important key feature of NMS. EPS, associated
and considerably elevated ... creatine kinase (CK ... NeurolepticMalignant #Comparison #Table